Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 24, 2025
Microsize announced it has signed an agreement to acquire Micro-Macinazione (Mic Mac), a dedicated micronization facility in Monteggio, Switzerland, from Lonza.
read more
Monday, November 24, 2025
HRV Global Life Sciences announced a multi-year Contract Development & Manufacturing (CDMO) partnership with MetroChem API Pvt. Ltd. which will focus on the exclusive and semi-exclusive development, scale-up, and GMP manufacturing of multiple high-...
read more
Thursday, November 20, 2025
TetraScience announced that Bayer AG will expand its deployment of TetraScience's Scientific Data Foundry across its pharmaceutical and crop science R&D operations.
read more
Thursday, November 20, 2025
Cellipont Bioservices announced a strategic collaboration with Ronawk to accelerate the scalable expansion of high-quality mesenchymal stem cells (MSCs). The partnership addresses key industry challenges in scalability, consistency, capital ...
read more
Thursday, November 20, 2025
Antheia and TAPI – Technology and API Services, announced a strategic partnership. Antheia will leverage TAPI's next-generation fermentation capabilities and manufacturing facilities in Europe to further commercialize its pipeline of biosynthetic key...
read more
Wednesday, November 19, 2025
Piramal Pharma Solutions announced that its Grangemouth, UK facility has received updated MHRA GMP certificates following a successful compliance report and desktop inspection.
read more
Tuesday, November 18, 2025
LSL Pharma Group has completed the acquisition of Laboratoire Du-Var Inc. a contract manufacturer of cosmetics and natural health products established in 1947.
read more
Tuesday, November 18, 2025
CRScube has announced the successful acquisition of Mednet. The transaction unites two respected eClinical technology vendors with complementary strengths and a shared commitment to thoughtful innovation, collaboration, and care for the people behind...
read more
Tuesday, November 18, 2025
Advocate Health announced the formation of Advocate Health National Center for Clinical Trials, a first-of-its-kind, fully integrated solution designed to accelerate discovery by making participation in health care research part of the standard-of-...
read more
Tuesday, November 18, 2025
Kytopen, a provider of continuous flow cellular engineering technologies and Excellos, a cell therapy CDMO and member of Blood Centers of America (BCA), announced that the two companies are exploring a collaboration to advance non-viral cell therapy ...
read more
Tuesday, November 18, 2025
BioDuro announced the launch of a new Business Unit (BU) dedicated to advancing peptide drug discovery and development for its global biopharma partners, underscoring the company’s commitment to strengthening its peptide technology platform to meet ...
read more
Monday, November 17, 2025
Evonik has entered a strategic partnership with InVitria to supply animal component-free (ACF) recombinant human serum albumin to the global biopharmaceutical industry.
read more
Thursday, November 13, 2025
AES Cleanroom Technology has opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast’s fast-growing life sciences, biotechnology, and advanced manufacturing sectors.
read more
Thursday, November 13, 2025
GenoSafe inaugurated its new 1,200 m² laboratories at the Genopole biocluster in Évry-Courcouronnes, designed and equipped in accordance with Good Manufacturing Practices (GMP).
read more
Thursday, November 13, 2025
Genezen and Humane announced a partnership for process transfer and cGMP manufacturing of HGI627, a novel therapy targeting pediatric liver cancer (hepatoblastoma).
read more